株式会社FerroptoCure

About

is developing a new generation of cancer therapies based on ferroptosis, a cell death mechanism that is still under-exploited in current treatments. With a strong academic base, the startup is seeking to accelerate its clinical partnerships and establish collaborations with biomedical research stakeholders in Europe to take the next step in validation.